PISCATAWAY, N.J. – Camber Pharmaceuticals has expanded its women’s health portfolio by launching clomiphene citrate tablets, USP, a generic version of Clomid.
The prescription medication is used to stimulate ovulation in patients with documented ovulatory dysfunction, a condition that can contribute to fertility challenges.
Camber’s clomiphene citrate tablets are available in 50 mg strength in cartons of 10 or 30 tablets.
According to the National Institute of Child Health and Human Development (NICHD), 14% to 25% of women experience irregular menstrual cycles, which may be linked to hormonal imbalances and other reproductive health concerns. However, not all menstrual irregularities involve ovulatory dysfunction.
Clomiphene citrate is indicated for patients with confirmed ovulatory dysfunction who meet specific medical criteria. Patients must not be pregnant, have normal liver function, and not have abnormal vaginal bleeding or ovarian cysts. The medication should also not be used in patients with ovarian enlargement, except those with polycystic ovary syndrome.
The launch adds another generic treatment option to Camber’s portfolio of prescription medications.
Additional product information is available on Camber’s website.
Submit Your Press Release
Have news to share? Send us your press releases and announcements.
Send Press Release
